KBI Biopharma, Inc.
Cell Line Development
Process Development
Analytical Development
Formulation Development
Characterization
Clinical Manufacturing
Commercial Manufacturing
Standalone Services Portal
Purification
Particle Characterization
Biophysical Characterization
Mass Spectrometry Core Facility
Clinical Mammalian
Clinical Microbial
Clinical Release & Stability
Commercial Mammalian
Commercial Microbial
Commercial Release & Stability
PUREplatform™
Biopharmaceutical Development
Biopharmaceutical Manufacturing
Advanced Mass Spectrometry for Characterization and Quantitation of APIs and Impurities in Complex B
Mammalian Cell Line Development
Microbial Cell Line Development
Cell Culture Process Development
Fermentation Process Development
Purification Process Development
Clinical Mammalian Manufacturing
Clinical Microbial Manufacturing
Commercial Mammalian Manufacturing
Commercial Microbial Manufacturing
Locations
Development and Manufacturing Services for New Biologics
Process, Analytical, Formulation Development
Protein production services
Plasmid and strain supply
Biopharmaceutical manufacturing support
Sample Management
Analytical Services
Quality Systems
Submission-Ready Reports
Commercial Release & Stability Services
Identity Testing
Strength Testing
Purity Testing
Potency Testing
Safety Testing
Quality Testing
会社名
Group 親会社 子会社 得意先 仕入先 業務提携 銀行等 株主等

1 件
日付概要
2024-11-13 - Picture of KBI Biopharma - KBI Biopharma
+ 開くと読み込みます
2026-06-12 17:48 (Model: ggml-org/gpt-oss-20b )
↑